Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis

doi:10.3748/wjg.v13.i23.3259

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2797)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

351

HTML

2215

Figures (1-3)

231

Sum=2797

Jun 21, 2007 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jun 21, 2007; 13(23): 3259-3261
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3259

Full Size Figure Download Figure

Figure 3 Enhanced computed-tomography (CT) scans in the arterial phase (A) and equilibrium phase (B) after administration of ACE-I in combination with VK. After a 15-mo administration, the hepatic nodule disappeared in both the arterial phase and equilibrium phase.

Citation: Yoshiji H, Noguchi R, Yamazaki M, Ikenaka Y, Sawai M, Ishikawa M, Kawaratani H, Mashitani T, Kitade M, Kaji K, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Yoshida M, Fukui H. Combined treatment of vitamin K₂ and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis. World J Gastroenterol 2007; 13(23): 3259-3261
URL: https://www.wjgnet.com/1007-9327/full/v13/i23/3259.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i23.3259